News · Healthcare · Published 10 July 2026
Swedish regulator warns against diabetes supplement promoted through fake AI videos
Läkemedelsverket says Insulinorm is not an approved diabetes treatment and warns patients not to abandon prescribed medicine after seeing deceptive online ads.
DailySweden Editorial Desk
Updated 23:33 · 3 min read
Listen to this articleNarrated - 9:12
Sweden’s Medical Products Agency has warned consumers about Insulinorm, a dietary supplement being promoted online as a treatment or cure for diabetes.
Läkemedelsverket said it had found extensive advertising for the product across websites and social media. The marketing includes false videos created with artificial intelligence and presents the supplement as if it were a medicine capable of treating the disease.
The agency said Insulinorm is not approved for treating diabetes and has no known effect against the condition. Its warning focuses on the danger that patients may stop taking medicine prescribed by a doctor and use the supplement instead.
Läkemedelsverket says Insulinorm is not an approved diabetes treatment and warns patients not to abandon prescribed medicine after seeing deceptive online ads.
Officials said they had received indications that some people were considering ending their existing treatment in favour of the advertised product. Läkemedelsverket urged patients to rely on their doctor’s assessment and continue following their prescribed treatment.
Healthcare essentials
The agency said untreated diabetes can become life-threatening and lead to very serious conditions. Anyone who is uncertain about their medication should speak to their doctor before making a change.
According to Läkemedelsverket, scam advertisements claiming that products can cure illnesses are a common way to mislead consumers. Products intended to treat diabetes must be approved as medicines and prescribed by a doctor. A product offered without a prescription or medical assessment while claiming to treat the disease should therefore be treated as a warning sign.
What happens now
The case remains under investigation. Läkemedelsverket said it chose to alert consumers before that work was complete because of the potential consequences of patients interrupting prescribed treatment.
For people who encounter the advertising, the immediate message is straightforward: the supplement is not an approved diabetes medicine, and online claims should not replace an individual medical assessment. Patients should continue their prescribed treatment unless their doctor advises a change.
DailySweden Editorial Desk
Original DailySweden guide desk. We write practical Sweden explainers for newcomers and update them when official guidance changes.
Contact the editorial desk ›
